（编辑 袁冠琳） 证券日报网讯 2月9日，交控科技发布公告称，公司已与MetroTrainsWestPtyLtd签署了澳大利亚悉尼地铁 西线TSMO信号系统分包项目协议，合同金额为93，530，364.97澳大利亚元。 ...

Group 1 - Huatai Medical plans to repurchase shares worth between 150 million to 200 million yuan for employee stock ownership plans or equity incentives, with a repurchase price not exceeding 315 yuan per share [1][3] - Aopt plans to raise no more than 1.38 billion yuan for projects related to AI intelligent vision solutions and industrial 3D vision sensors [1][4] - Weimais reported a net profit of 557 million yuan for 2025, a year-on-year increase of 39.22%, despite a slight decline in total revenue [1][6] Group 2 - Jiaokong Technology signed a contract for the Sydney Metro West Line TSMO signal system subcontract project, with a contract value of approximately 93.53 million Australian dollars [1][5] - Microelectrophysiology received EU MDR certification for its magnetic navigation ablation catheter and star-shaped high-density mapping catheter, facilitating entry into the European market [1][4] - Firmus Technologies, an Australian AI infrastructure company, secured 10 billion USD in debt financing led by Blackstone for data center expansion [8][9]

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

悉尼地铁西线信号系统分包合同的签署，标志着公司在拓展国际轨道交通市场方面迈出了重要一步，也 体现了公司国际化战略实施的持续进展。若合同顺利执行，预计将在项目实施期间对公司产生积极影 响。 智通财经APP讯，交控科技(688015.SH)发布公告，公司已与Metro Trains West Pty Ltd签署了澳大利亚悉 尼地铁西线TSMO(车辆、系统、维护、运营)信号系统分包项目协议，合同金额为：9353.04万澳大利亚 元(按2月9日的汇率，折合人民币约4.56亿元，含交付、不含安装)。 ...

交控科技公告，公司与Metro Trains West Pty Ltd签订合同金额为9353.04万澳大利亚元的项目协议。根据 该合同，公司将在项目交付阶段提供FAO系统，以支持全线列车全自动运行。 ...

Group 1 - The company, Jiaokong Technology (688015.SH), has signed a subcontract agreement for the Sydney Metro West Line TSMO (Train, Systems, Maintenance, and Operations) signaling system project with Metro Trains West Pty Ltd [1] - The contract amount is 93.5304 million Australian dollars, which is approximately 456 million RMB based on the exchange rate on February 9, 2023, including delivery but excluding installation [1]

证券代码：688015 证券简称：交控科技 公告编号：2026-003 交控科技股份有限公司 风险提示：本项目收入依据合同在履约期间确认，因项目需跨年分期实 施，本项目对于2026年度当期业绩影响存在不确定性。在合同履行过程中，受 外部宏观环境重大变化、国家有关政策变化，或客户需求产生不利变化以及其 他不可预见或不可抗力等因素的影响，可能会导致合同无法如期或全面履行， 敬请广大投资者注意投资风险。 交控科技股份有限公司与Metro Trains West Pty Ltd于近日签订《悉尼地铁 西线TSMO合约信号系统分包项目》合同，合同金额为93,530,364.97 澳大利亚 元（含交付、不含安装）。公司履行了签署该合同相应的内部审批程序，签署 该合同无需提交公司董事会或股东会审批。 一、合同标的基本情况 关于自愿披露签订日常经营合同的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 合同内容及金额：交控科技股份有限公司（以下简称"公司"）已与 Metro Trains West Pty Ltd签署了澳 ...

每经AI快讯，2月9日，交控科技公告，公司与MetroTrainsWestPtyLtd于近日签订《悉尼地铁西线TSMO 合约信号系统分包项目》合同，合同金额为93,530,364.97澳大利亚元(按2月9日的汇率，折合人民币约 4.56亿元，含交付、不含安装)。公司履行了签署该合同相应的内部审批程序，签署该合同无需提交公 司董事会或股东会审批。 ...

（文章来源：证券日报） 证券日报网讯 2月4日，交控科技在互动平台回答投资者提问时表示，公司始终高度重视投资者关系管 理，对于投资者的提问，公司内部核实与履行内部审批流程需要一定的时间。 ...

Core Viewpoint - The company is focusing on its core business in rail transit while actively responding to national strategies in the low-altitude economy sector [2] Group 1: Business Focus - The company's main business centers around rail transit [2] - The company is exploring the application of its technologies in low-altitude scenarios, leveraging its expertise in intelligent scheduling, safety protection, and system integration from the rail transit control field [2] Group 2: Product Development - The company is advancing product research and technology application in the low-altitude economy, aiming to build a "low-altitude operation platform + AI brain" core architecture [2] - The company has successfully empowered various practical business scenarios, including rail transit inspection, comprehensive government affairs, and river management, receiving widespread recognition and praise from users in these fields [2] Group 3: Technological Advancements - The company is increasing its efforts in developing applications for closed-space scenarios and specialized drone development [2] - The closed-space inspection drone developed by the company has completed core technology validation and is currently progressing with pilot application work [2]